US trade rep is pressing Indian government to forbid production of generic cancer drug, consortium says

@article{Cohen2014USTR,
  title={US trade rep is pressing Indian government to forbid production of generic cancer drug, consortium says},
  author={Deborah Cohen},
  journal={BMJ : British Medical Journal},
  year={2014},
  volume={349}
}
  • D. Cohen
  • Published 4 November 2014
  • Medicine
  • BMJ : British Medical Journal
The US government’s opposition to the generic manufacture of a cancer drug has been described as an “endorsement of excessive pricing, a rejection of the goal of access to medicine for all, and a death sentence for leukaemia patients” in a letter from an international network of people affected by cancer. The letter, written by the Union for Affordable Cancer Treatment to Michael Froman, the US trade representative, alleged that he is using his position to pressure the Indian government to… 
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib
TLDR
The data suggest treatment with dasatinib as a promising new therapeutic option for patients suffering from DDR2 overexpressing HNSCC and propose to test this drug in clinical trials so that patients could directly benefit from this new treatment option.